EUVIMEDEUVIMED entdecken
Crossref

Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experience

Hany Elbeshbeshy, Neal Modi iD, Twinkle Patel, Ian Matthews, Timothy Kampert, Jaenic Lee, Raymond Okeke, Yasar Caliskan, Vidyaratna Fleetwood, Chintalapati Varma, Brittney Gabris, Bahar Bastani und 11 weitere

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15161 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Hany Elbeshbeshy und 22 weiteren Autor:innen. Beteiligte Einrichtung: Center for Abdominal Transplantation, SSM Health Saint Louis University Hospital, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Hepatitis C, Chronic, Hepatitis C. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With the introduction of direct‐acting antiviral therapies (DAAs), the non‐use rate of hepatitis C virus (HCV)‐positive donor organs (D+) has decreased significantly. We present the donor, recipient, and transplant allograft characteristics, along with recipient outcomes, in one of the largest cohorts of HCV‐D+ transplants into HCV‐naïve recipients (R−).

Methods

Charts of HCV D+/R− kidney (KT), liver (LT), and simultaneous liver‐kidney (SLKT) transplant recipients between January 2019 and July 2022 were reviewed. Primary outcomes of interest included waitlist times and 1‐year graft failure. Secondary outcomes included hospital and intensive care unit length of stay, post‐transplant complications, effectiveness of DAA therapy, and characteristics of patients who relapsed from initial DAA therapy.

Results

Fifty‐five HCV D+/R− transplants at our center [42 KT (26 nucleic acid testing positive [NAT+], 16 NAT−), 12 LT (eight NAT+, four NAT−), and one SLKT (NAT+)] had a median waitlist time of 69 days for KT, 87 days for LT, and 15 days for SLKT. There were no graft failures at 1 year. All viremic recipients were treated with a 12‐week course of DAAs, of which 100% achieved end of treatment response (EOTR)—85.7% ( n = 30) achieved sustained virologic response (SVR) and 14.3% relapsed ( n = 5; four KT, one LT). All relapsed recipients were retreated and achieved SVR. The most common post‐transplantation complications include BK virus infection ( n = 9) for KT and non‐allograft infections ( n = 4) for LT.

Conclusions

Our study has demonstrated no graft failures or recipient deaths at 1 year, and despite a 14.3% relapse rate, we achieved 100% SVR. Complications rates of D+/R− appeared comparable to national D−/R− complication rates. Further studies comparing D+/R− to D−/R− outcomes are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationHepatitis C, ChronicHepatitis CHumansHepacivirusAntiviral AgentsTissue DonorsKidney

Stichwörter der Autor:innen

agentsdeceaseddonors and donationhepatitis Cinfection and infectiousunited network for organ sharing (UNOS)viral

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Center for Abdominal Transplantation, SSM Health Saint Louis University Hospital, St. Louis, Missouri, USA.
  • Saint Louis University School of Medicine, St. Louis, Missouri, USA.
  • Department of Surgery, Saint Louis University Hospital, St. Louis, Missouri, USA.

ORCID-Profile: Neal Modi, Mustafa Nazzal

Zitieren

APA

Elbeshbeshy, H., Modi, N., Patel, T., Matthews, I., Kampert, T., Lee, J., Okeke, R., Caliskan, Y., Fleetwood, V., Varma, C., Gabris, B., Bastani, B., Abu Al Rub, F., Guenette, A., Befeler, A., Agbim, U., Desai, R., Alsabbagh, E., Qureshi, K., …, & Nazzal, M. (2024). Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experience. Clinical Transplantation. https://doi.org/10.1111/ctr.15161

Vancouver

Elbeshbeshy H, Modi N, Patel T, Matthews I, Kampert T, Lee J, et al. Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experience. Clinical Transplantation. 2024. doi:10.1111/ctr.15161

BibTeX
@article{Elbeshbeshy2024,
  author = {Elbeshbeshy, Hany and Modi, Neal and Patel, Twinkle and Matthews, Ian and Kampert, Timothy and Lee, Jaenic and Okeke, Raymond and Caliskan, Yasar and Fleetwood, Vidyaratna and Varma, Chintalapati and Gabris, Brittney and Bastani, Bahar and Abu Al Rub, Fadee and Guenette, Alexis and Befeler, Alex and Agbim, Uchenna and Desai, Roshani and Alsabbagh, Eyad and Qureshi, Kamran and Schnitzler, Mark and Lentine, Krista L and Randall, Henry B and Nazzal, Mustafa},
  title = {Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experience},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15161}
}
Kostenlos starten →